
    
      Eligible women will be invited by their primary care physician to participate in the study.
      After signing an informed consent women will be randomized to receive oral vitamin D 100,000
      IU or similar placebo once a month for three consecutive months. Pertinent clinical and
      demographic date will be documented and relevant laboratory test will be performed by the
      primary care team. One month after the third dose the same data and tests will be retrieved
      on each woman. Compliance with the study protocol will be enhanced and confirmed by a
      research assistant.

      Objectives:

      To assess the relationship between IFG and 25(OH) vitamin D levels in overweight Arab women.

      To assess whether vitamin D supplementation significantly improves IFG. To assess whether
      vitamin D supplementation significantly modifies IL-10 and hs-CRP.
    
  